Table 1 Demographic and clinical characteristics
From: Prevalence of foot problems in people with inflammatory arthritis in Singapore
Age, years | 52.0 (14.5) |
|---|---|
Women, n (%) | 51 (50Â %) |
Ethnicity, n (%) | |
 Chinese | 70 (69 %) |
 Malay | 11 (11 %) |
 Indian | 15 (15 %) |
 Caucasian | 0 (0 %) |
 Other | 5 (5 %) |
 Body Mass Index, Kg/m2 | 27.2 (5.4) |
 Smokers, n (%) | 14 (14 %) |
 Disease duration, years | 9.3 (0.3) |
Disease type, n (%) | |
 • Rheumatoid arthritis | 46 (46 %) |
 • Gout | 31 (31 %) |
 • Spondyloarthritis | 15 (15 %) |
 • Psoriatic arthritis | 4 (4 %) |
 • Undifferentiated inflammatory arthritis | 5 (5 %) |
Medications, n (%) | |
 • Methotrexate | 42 (60 %) |
 • Combination DMARD therapy (≥2 DMARDs) | 52 (74 %) |
 • Biologics | 4 (6 %) |
 • Prednisone | 40 (40 %) |
Other medications, n (%) | |
 NSAID, n (%) | 49 (49 %) |
 Diabetes Mellitus, n (%) | 12 (12 %) |
 Patient global VAS (VAS 0–100), mm | 26 (26) |
 Tender (28) joint count | 1.8 (2.8) |
 Swollen (28) joint count | 1.3 (2.1) |
 DAS28-ESR score | 3.54 (1.1) |
 ESR, mm/h | 31.6 (21.2) |
 CRP, mg/L | 27.4 (32.2) |
 mHAQ score | 0.25 (0.36) |